Blair Q Ferguson

Title: The Innovations of Blair Q Ferguson

Introduction

Blair Q Ferguson is an accomplished inventor based in Wilmington, Delaware. He has made significant contributions to the field of biotechnology, particularly in the development of stable human cell lines. His work has implications for various applications in medical research and pharmaceutical development.

Latest Patents

Ferguson holds a patent for "Stable human cell lines expressing an indicator gene product." This invention relates to stable mammalian cell lines that have integrated two heterologous DNA sequences into their genome. The first DNA sequence expresses a trans-acting regulatory protein, while the second DNA sequence expresses a desired protein. This second sequence is linked to a target DNA regulatory control sequence that responds to the expressed trans-acting regulatory protein. This innovation is crucial for advancing research in gene expression and therapeutic applications.

Career Highlights

Blair Q Ferguson has had a notable career at Du Pont Merck Pharmaceutical, where he has been instrumental in various research initiatives. His expertise in genetic engineering and cell line development has positioned him as a valuable asset in the pharmaceutical industry. His work has contributed to the advancement of biopharmaceuticals and therapeutic solutions.

Collaborations

Ferguson has collaborated with several esteemed colleagues, including Lee Terry Bacheler and Stephen R Petteway. These collaborations have fostered a productive research environment, leading to innovative solutions in biotechnology.

Conclusion

Blair Q Ferguson's contributions to the field of biotechnology through his patent and work at Du Pont Merck Pharmaceutical highlight his role as a significant inventor. His innovations continue to impact medical research and pharmaceutical development positively.